B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses.
Immune evasion by tumors includes several different mechanisms, including the inefficiency of antigen presenting cells (APCs) to trigger anti-tumor T cell responses. B lymphocytes may display a pro-tumoral role but can also be modulated to function as antigen presenting cells to T lymphocytes, capab...
Main Authors: | Renata Ariza Marques Rossetti, Noely Paula Cristina Lorenzi, Kaori Yokochi, Maria Beatriz Sartor de Faria Rosa, Luciana Benevides, Paulo Francisco Ramos Margarido, Edmund Chada Baracat, Jesus Paula Carvalho, Luisa Lina Villa, Ana Paula Lepique |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6033398?pdf=render |
Similar Items
-
HPV vaccination: the beginning of the end of cervical cancer? - A Review
by: Ana Paula Lepique, et al.
Published: (2009-02-01) -
Lymphocyte Differentiation and Effector Functions
by: Niels Olsen Saraiva Camara, et al.
Published: (2012-01-01) -
Partial vaginal expulsion of a leiomyosarcoma
by: Kaori Yokochi, et al.
Published: (2013-06-01) -
Ovarian Cancer Previvors: How to manage these patients?
by: Jesus Paula Carvalho, et al. -
The acceptability of vaginal smear self-collection for screening for cervical cancer: a systematic review
by: Natalia Serrano Doratioto Faria Braz, et al.